Neurogenetics

In September 2022, two New Zealand patients became the first in the world to participate in a phase 1 clinical trial testing a new therapy for a rare neurogenetic condition called myotonic dystrophy… Audio

Two New Zealand patients will be the first participants in the world to join a phase 1 clinical trial to test the safety of a new therapy for myotonic dystrophy – a rare neurogenetic condition. It's… Audio